Michael Brian Bell sold $261k of GH
Chief Financial Officer at Guardant Health, Inc.. 3,000 shares at an average of $87.04, traded Mar 16, 2026, filed Mar 17, 2026.
Score components
- +22RoleCFO
- +13Trade size$261k at market
- 0Share of holdings soldSold 6.4% of holdings
- +15Cluster4 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -3.4%, 3m +43.5%, 6m +97.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001702824-26-000006, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 15, 2026 | MOption exercise Common Stock | +1,233 | $0.00 | $0 | 41,457 | Mar 17, 2026 |
| Mar 15, 2026 | MOption exercise Common Stock | +10,518 | $0.00 | $0 | 51,975 | Mar 17, 2026 |
| Mar 15, 2026 | MOption exercise Common Stock | +2,039 | $0.00 | $0 | 54,014 | Mar 17, 2026 |
| Mar 15, 2026 | FTax withholding Common Stock | -7,413 | $85.49 | $634k | 46,601 | Mar 17, 2026 |
| Mar 16, 2026 | SOpen-market sale Common Stock | -3,000 | $87.04 | $261k | 43,601 | Mar 17, 2026 |
| Mar 15, 2026 | MOption exercise Restricted Stock Unitsderivative | -1,233 | $0.00 | $0 | 0 | Mar 17, 2026 |
| Mar 15, 2026 | MOption exercise Performance-Based Restricted Stock Unitsderivative | -10,518 | $0.00 | $0 | 0 | Mar 17, 2026 |
| Mar 15, 2026 | MOption exercise Restricted Stock Unitsderivative | -2,039 | $0.00 | $0 | 2,039 | Mar 17, 2026 |
Related signals
Other insiders at Guardant Health, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 41Moderate | Guardant Health, Inc. | Alex M Azar II director | $145k 826 shares | -50% | |
| 55Moderate | Guardant Health, Inc. | Darya Chudova Chief Technology Officer | $1.4M 7,738 shares | -10% | |
| 65Notable | Guardant Health, Inc. | Steve E. Krognes director | $1.2M 6,674 shares | -46% | |
| 0Weak | Guardant Health, Inc. | Musa Tariq director | $20k 116 shares | -1% | |
| 50Moderate | Guardant Health, Inc. | Kumud Kalia Chief Information Officer | $632k 4,000 shares | -9% | |
| 85Strong | Guardant Health, Inc. | AmirAli Talasaz Co-Chief Executive Officer | $6.3M 37,500 shares | -50% | |
| 0Weak | Guardant Health, Inc. | Musa Tariq director | $18k 116 shares | -1% | |
| 60Notable | Guardant Health, Inc. | Terilyn J. Monroe Chief People Officer | $7.6M 46,300 shares | -67% | |
| 50Moderate | Guardant Health, Inc. | Chris Freeman Chief Commercial Officer | $11M 63,605 shares | -49% | |
| 39Weak | Guardant Health, Inc. | Medina Manuel Hidalgo director | $279k 1,700 shares | -27% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.